Aptamer-based Influenza Detection Device

About Novaptech

Novaptech is a private, revenue-generating biotechnology CRO and platform company focused on aptamer development. Spun out from an academic lab with over 30 years of aptamer expertise, the company offers end-to-end custom aptamer services and is developing its own pipeline of aptamer-based diagnostic kits and biosensors. With a global client base and a focus on replacing antibodies in various applications, Novaptech positions itself at the forefront of synthetic ligand technology for quantitative detection and point-of-care testing.